Cargando…

Efficacy of re-resection versus radiofrequency ablation for recurrent Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma (HCC) after resection for primary HCC

BACKGROUND: Whether repeat surgical resection (RSR) or radiofrequency ablation (RFA) is a better option for recurrent hepatocellular carcinoma (HCC) after resection for primary HCC remains controversial. This study was to investigate the clinical efficacy of RSR versus RFA in the treatment of recurr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Xieling, Hua, Tianqi, Liang, Chi, Chen, Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797533/ https://www.ncbi.nlm.nih.gov/pubmed/35116847 http://dx.doi.org/10.21037/tcr.2019.06.11

Ejemplares similares

Comparable and Complimentary Modalities for Treatment of Small-Sized HCC: Surgical Resection, Radiofrequency Ablation, and Microwave Ablation
por: Wicks, Jeffrey S., et al.
Publicado: (2023)

Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC
por: Deshpande, Rahul, et al.
Publicado: (2011)

Liver resection is always a good choice for hepatocellular carcinoma (HCC) patients regardless of Barcelona Clinic Liver Cancer (BCLC) stage: the therapeutic hierarchy
por: Guarino, Maria, et al.
Publicado: (2020)

Radiofrequency ablation versus resection for Barcelona clinic liver cancer very early/early stage hepatocellular carcinoma: a systematic review
por: He, Zhen-Xin, et al.
Publicado: (2016)

Survival Analysis of Re-resection Versus Radiofrequency Ablation for Intrahepatic Recurrence After Hepatectomy for Hepatocellular Carcinoma
por: Chan, Albert C. Y., et al.
Publicado: (2011)

Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies
por: Pal Chaudhary, Surendra, et al.
Publicado: (2023)

Robotic Liver Resection Versus Percutaneous Ablation for Early HCC: Short- and Long-Term Results
por: Magistri, Paolo, et al.
Publicado: (2020)

Comparison of repeated surgical resection and radiofrequency ablation for small recurrent hepatocellular carcinoma after primary resection
por: Sun, Wei-Chi, et al.
Publicado: (2017)

Treatment optimization for recurrent hepatocellular carcinoma: Repeat hepatic resection versus radiofrequency ablation
por: Lu, Liang‐He, et al.
Publicado: (2020)

Radiofrequency ablation versus hepatic resection for recurrent hepatocellular carcinoma: an updated meta-analysis
por: Yang, Daopeng, et al.
Publicado: (2020)

Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma
por: Liang, Bin, et al.
Publicado: (2018)

Repeat hepatic resection combined with intraoperative radiofrequency ablation versus repeat hepatic resection alone for recurrent and multiple hepatocellular carcinoma patients meeting the Barcelona Clinic Liver Cancer stage A: A propensity score‐matched analysis
por: Huang, Yang, et al.
Publicado: (2023)

Case report and literature review: Isolated HCC- recurrence in gallbladder after curative resection
por: Zhang, Shi-Ran, et al.
Publicado: (2023)

Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011)

Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes
por: Campani, Claudia, et al.
Publicado: (2020)

Surgical Resection or Radiofrequency Ablation for Small Hepatocellular Carcinoma
por: Feng, Qingbo, et al.
Publicado: (2022)

Surgical Resection or Radiofrequency Ablation for Small Hepatocellular Carcinoma
por: Kawaguchi, Yoshikuni, et al.
Publicado: (2023)

Transarterial chemoembolization as a substitute to radiofrequency ablation for treating Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma
por: Ishikawa, Kentaro, et al.
Publicado: (2018)

Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression
por: Kotsari, Maria, et al.
Publicado: (2023)

Radiofrequency Ablation Versus Surgical Resection for Small Unifocal Hepatocellular Carcinomas
por: Lei, J.Y., et al.
Publicado: (2014)

Impact of multiple liver resections prior to salvage liver transplantation on survival in patients with recurrent HCC
por: Hu, Zhenhua, et al.
Publicado: (2015)

Radiofrequency ablation combined with transcatheter arterial chemoembolization therapy versus surgical resection for Barcelona-Clinic Liver Cancer (BCLC) A hepatocellular carcinoma: a meta-analysis
por: Wang, Weidong, et al.
Publicado: (2019)

Influence of surgical approach and quality of resection on the probability of cure for early-stage HCC occurring in cirrhosis
por: Hobeika, Christian, et al.
Publicado: (2020)

Prognostic evaluation of HCC patients undergoing surgical resection: an analysis of 8 different staging systems
por: Bednarsch, Jan, et al.
Publicado: (2020)

Human Hepatocellular Carcinoma (HCC)
por: Buonaguro, Luigi
Publicado: (2020)

PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma
por: Pinato, David J., et al.
Publicado: (2021)

A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE
por: Hu, Shuyang, et al.
Publicado: (2021)

Histological Correlation for Radiofrequency and Microwave Ablation in the Local Control of Hepatocellular Carcinoma (HCC) before Liver Transplantation: A Comprehensive Review
por: Habibollahi, Peiman, et al.
Publicado: (2020)

Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma
por: Zhou, Yanming, et al.
Publicado: (2010)

Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection
por: von Felden, Johann, et al.
Publicado: (2017)

Integrated nomograms to predict overall survival and recurrence-free survival in patients with combined hepatocellular cholangiocarcinoma (cHCC) after liver resection
por: Wang, Tao, et al.
Publicado: (2020)

Radiofrequency ablation versus surgical resection in elderly patients with early-stage hepatocellular carcinoma in the era of organ shortage
por: Yu, Bin, et al.
Publicado: (2018)

Ablative Therapy in Non-HCC Liver Malignancy
por: Robinson, Tyler P., et al.
Publicado: (2023)

Is the anatomical resection necessary for single hepatocellular carcinoma smaller than 3 cm?: single-center experience of liver resection for a small HCC
por: Shin, Sungwook, et al.
Publicado: (2018)

Tumor Regression in HCC Patient with Portal Vein Tumor Thrombosis after Intraportal Radiofrequency Thermal Ablation
por: Mizandari, Malkhaz, et al.
Publicado: (2016)

Preoperative inflammatory markers of NLR and PLR as indicators of poor prognosis in resectable HCC
por: Wang, Dong, et al.
Publicado: (2019)

Time to surgery is not an oncological risk factor in HCC patients undergoing liver resection
por: Otto, Carlos Constantin, et al.
Publicado: (2023)

Tenofovir vs Entecavir Among Patients With HBV-Related HCC After Resection
por: Li, Pengpeng, et al.
Publicado: (2023)

MRI in detection of hepatocellular carcinoma (HCC)
por: Digumarthy, Subba R, et al.
Publicado: (2005)

Emerging Therapies for Hepatocellular Carcinoma (HCC)
por: Chakraborty, Eesha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_95fm8hv4gkg2cfqfeumgugf2lh